The options have an exercise price of
About
Contact:
CBO & CFO
T: 857-999-0890
E: ben.palleiko@kalvista.com
(C) 2022 Electronic News Publishing, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.97 USD | -1.84% |
|
+19.09% | +22.20% |
07-12 | Needham Adjusts Price Target on KalVista Pharmaceuticals to $32 From $35, Maintains Buy Rating | MT |
07-11 | KalVista Pharmaceuticals Files $300 Million Mixed Shelf | MT |
The options have an exercise price of
About
Contact:
CBO & CFO
T: 857-999-0890
E: ben.palleiko@kalvista.com
(C) 2022 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+22.20% | 652M | |
+7.46% | 100B | |
+11.97% | 42.34B | |
-11.76% | 32.76B | |
+79.34% | 29.46B | |
-12.20% | 16.31B | |
+4.00% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B |